131 Comments

1. Very disturbing to hear of the problems your friend C.J. Hopkins is having in Germany. Keep us informed.

   1. CJ is experiencing an outpouring of support which is cheering him up!

   2. Nelson, Here is a link to his crowdfunding page: https://www.freefunder.com/campaign/cj-hopkins-legal-fund?utm_source=substack&utm_medium=email
      Have a wonderful weekend, Jen

2. Confiscation of farmland in Holland reminds me of what the Bolsheviks did in Russia and Ukraine. They called it collectivization.

   1. Holland – Netherland executes on a close to 80% socialism with a strong gov welfare system, education is regulated since you are born, min/max salaries, taxes and many social measurements. Unless you are super wealthy, there is no much freedom for the average individual. Traveling, unless close to home is very unlikely. They have implemented smart – city initiatives and are a source of a lot of software/tech/science R&D for exports benefiting the gov and wealthy, green energy ideation and transportation control for the masses. Collectivism is at the base, not individualism, which points to socialistic measurements.

3. I have not listened to the M&M yet but I am watching the ensuing elections in The Netherlands. I use your experience with all the time you spend there to have great hope the election scenario that could change things is successful. Would really like to see that as the road to change. Would not mind getting a talking to on having patience with the system, Then again, we’ll see. ?

4. Just a quick note about something I am seeing in 2022 medical records. Patients who test positive for Covid-19 offered a drug called Paxlovid. Paxlovid is a Pfizer combination drug including Nirmatrelvir/Ritonavir. It was recently FDA approved, May, 2023, for treatment of Convid. Ritonavir was previously used for HIV and this really struck me because I was an HIV drug research nurse in the 1990’s, and I remember this drug, Ritonavir, was used in combination HIV treatment/study drugs in the 90’s. I seem to recall that Anthony Fauchi was involved there somewhere, with all of the HIV drugs, including the Ritonavir. I think he was behind the whole HIV drug research machine, at that time, but not certain. I think that quick studies of this drug to treat Convid were in put in place when EUA sham went up. HIV, Convid, EUA, Fauchi, antiretrovirals, quick FDA approval, brought to you by Pfizer and offered to patients prior to FDA approval? As Joseph would say, its one of those things that makes you go hmmmm. Not seeing a lot of this drug going out. Not yet but will keep watch and update.

   1. Ritonovir went generic in 2020, about the same time EUA went up.
      Ritonavir was patented in 1989 and came into medical use in 1996. It is on the World Health Organization’s List of Essential Medicines. Ritonavir capsules were approved as a generic medication in the United States in 2020.
      Paxlovid patent landscape: At present, much of what we know about Paxlovid’s patent landscape comes from a voluntary license agreement between Medicines Patent Pool (MPP) and Pfizer. This was devised to facilitate the granting of sub-licenses to qualified generic manufacturers in 95 countries (mostly low- and lower-middle-income countries) for the production of generic versions of Paxlovid.
      Exhibit B of the MPP-Pfizer license agreement details that Pfizer has only one patent family related to the Paxlovid product which, as of this writing, has no granted patents. The “international” PCT application PCT/IB2021/057281 listed was expected to publish in Mar. 2022 (18 months from the earliest priority date of Sep. 3, 2020 – see the four “inactive” U.S. patent applications mentioned in Exhibit B). However, Pfizer requested early publication of the PCT application; the application’s contents were made available to the public on Dec. 16, 2021 with a publication number of WO/2021/250648. https://www.citizen.org/article/paxlovid-patent-landscape/
      And from Washington post on 8/3/2023: “Opinion  The Checkup With Dr. Wen: Paxlovid is still underutilized. That must change”. https://www.washingtonpost.com/opinions/2023/08/03/paxlovid-covid-treatment-antiviral-pill/
      Again- hmmmm

   2. So that what I’m saying here is that pharmaceutical companies make more money on a drug that us “under patent” and exclusive to that drug company as a brand name drug, supposedly so that the pharmaceutical company can charge more for it, and has time for return on investment of the costs of studying and implementing that drug. After a specified period of time the drug goes off patent and “generic” and is no longer sold under an expensive brand name. The HIV drug Ritonavir went generic in the year 2020, just as covid hit and emergency use authorization (EAU) were implemented. The now generic HIV drug Ritonavir was repackaged in 2020 as a covid combination drug called Paxlovid, with a new patent application by Pfizer for the Paxolvid combination drug, containing Ritonavir, possibly putting Ritonavir back under patent as a covid drug.

   3. And how sick might the population get this Fall, with a subsequent big demand for Paxlovid prescriptions? The same Paxlovid that was introduced and pushed by the Washington Post on August 3, 2023. Right before we started hearing about new variants and mask mandates coming this Fall. Paxlovid, the repackaged HIV drug, may be aimed at the unvaccinated.

5. Catherine is there a way we can get the study by Dr Thomas on the vaccinated berths unvaccinated data. Being a healthcare provider it would be beneficial for my patients to have access to that data.
   Thank you
   James Stivaly

   1. James, Hello! Here is the link to the article:
      https://www.mdpi.com/1660-4601/17/22/8674
      Dr Paul Thomas’ article was “retracted” due to concerns an anonymous reader had about the larger number of sick kids with various illnesses like ear infections and gastritis were due to being vaccinated or not or the unvaccinated going to the well-baby visits. After some back and forth, the journal decided to pull that study.
      BUT, Dr James Lyons-Weiler and Dr Blaylock decided to do another study: “Revisiting Excess Diagnoses of Illnesses and Conditions in Children Whose Parents Provided Informed Permission to Vaccinate Them”
      https://ijvtpr.com/index.php/IJVTPR/article/view/59
      Here is an article in The Defender talking about the study above and Dr Paul Thomas as well.
      https://childrenshealthdefense.org/defender/study-unvaccinated-healthier-vaccinated-kids/
      And finally, here are links to articles that I find helpful from 2019 by Robert Kennedy entitled Vaccinated vs Unvaccinated part 1 & 2.
      BTW, There are more “parts”, I think he went up to 11 or more…you will find the links under the articles.
      https://childrenshealthdefense.org/child-health-topics/exposing-truth/fully-vaccinated-vs-unvaccinated/
      https://childrenshealthdefense.org/news/government-corruption/fully-vaccinated-vs-unvaccinated-part-2/
      Hope this helps, have a wonderful weekend.
      Jen

      1. The War on Informed Consent: The Persecution of Dr. Paul Thomas by the Oregon Medical Board (Children’s Health Defense) Hardcover – August 24, 2021
         by Jeremy R. Hammond (Author), Robert F. Kennedy Jr. (Foreword)

         1. Catherine, Yes! I forgot about that one! What a nightmare story! We need to get out from under the thumb of medical and nursing boards.
            Have a gorgeous weekend! I can’t wait to see photos of that theater! I bet it was wonderful!
            Hugs, Jen

6. Yesterday the traitor Emmanuel Goldstein accompanied by his entourage surrendered to the authorities in Georgia and was booked on charges of wrong think, disseminating misinformation and other crimes against the state that The Party is still investigating.

7. John & Catherine, any particular reason you don’t use a browser adblocker? Maybe because I’ve spent decades avoiding/blocking such advertising, the ads in the stories seem a distraction (grandma’s bra was a funny one).

   Pretty easily solved with a browser extension/add on (after a little tweaking to minimize site breakage).

Comments are closed.